1004550-20-2 Usage
Uses
Used in Pharmaceutical Industry:
3-bromoimidazo[1,2-a]pyridine-6-carbaldehyde is utilized as a key intermediate in the synthesis of new drugs. Its unique structure and reactivity make it a valuable building block for the development of pharmaceuticals with novel therapeutic properties.
Used in Material Science:
In the field of material science, 3-bromoimidazo[1,2-a]pyridine-6-carbaldehyde is employed as a precursor for the synthesis of novel materials. Its distinct chemical structure allows for the creation of new compounds with unique material properties, such as improved stability or enhanced functionality.
Used in Organic Synthesis:
3-bromoimidazo[1,2-a]pyridine-6-carbaldehyde is used as a reactive intermediate in various organic synthesis processes. Its bromine atom and aldehyde group facilitate a range of chemical reactions, enabling the production of diverse organic compounds with potential applications in different industries.
Used in Biological Activity Research:
3-bromoimidazo[1,2-a]pyridine-6-carbaldehyde has also been studied for its biological activity, with potential use as a building block in the synthesis of bioactive molecules. Its unique structure may contribute to the development of new compounds with significant biological effects, such as antimicrobial, antiviral, or anticancer properties.
Check Digit Verification of cas no
The CAS Registry Mumber 1004550-20-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,4,5,5 and 0 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1004550-20:
(9*1)+(8*0)+(7*0)+(6*4)+(5*5)+(4*5)+(3*0)+(2*2)+(1*0)=82
82 % 10 = 2
So 1004550-20-2 is a valid CAS Registry Number.
InChI:InChI=1S/C8H5BrN2O/c9-7-3-10-8-2-1-6(5-12)4-11(7)8/h1-5H
1004550-20-2Relevant academic research and scientific papers
THIOZOLIDINEDIONE DERIVATIVES AS P13 KINASE INHIBITORS
-
Page/Page column 54-55, (2008/06/13)
Invented is a method of inhibiting the activity/function of PB kinases using thiozolidinedione derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of thiozolidinedione derivatives.
